DAYLI Partners

Funding rounds backed by DAYLI Partners.

Export CSV
Funding disclosed in full
$89M
Median round
$44.5M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
BreezeBio

Develops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues

$60MSeries BBiotechUnited States
13 participantsACVC PartnersDAYLI PartnersDSC InvestmentKDB Silicon ValleyKiwoom InvestmentKorea Investment PartnersLoftyRock InvestmentPathway InvestmentSTIC VenturesSV InvestmentTop Harvest CapitalWoori Venture PartnersYuanta Investment
Galux

Develops AI-driven protein design platform for de novo antibody and drug discovery

$29MSeries BBiotechSouth Korea
10 participantsDAYLI PartnersInterVestKorea Development Bank (KDB)Korea Investment & SecuritiesMirae Asset SecuritiesNCORE VenturesPathway InvestmentSL InvestmentSneakPeek InvestmentsYuanta Investment